Arkolith/Insider Trading/TENX

TENX Insider Trading

TENX · full profile →Last filing May 11, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

76 shown
DateInsiderRoleActionSharesPriceValue
May 11, 2026Staab Thomas R IIChief Financial OfficerGrant(A)10K—$0
May 11, 2026Staab Thomas R IIChief Financial OfficerGrant(A)450K—$0
Jan 30, 2026McGauley ThomasInterim CFOOption exercise(M)50K—$0
Jan 9, 2026Proehl Gerald TDirectorGrant(A)3K—$0
Jan 9, 2026Almenoff June SherieDirectorGrant(A)30K—$0
Jan 9, 2026Davidson Michael H.DirectorGrant(A)30K—$0
Jan 9, 2026Doogan DeclanDirectorGrant(A)30K—$0
Jan 9, 2026Hunter RobynDirectorGrant(A)30K—$0
Jan 9, 2026Rich StuartChief Medical Officer, DirectorGrant(A)250K—$0
Jan 9, 2026Giordano Christopher ThomasCEO, DirectorGrant(A)450K—$0
Dec 9, 2025Rich StuartChief Medical Officer, DirectorBuy(P)3K$10.22$26K
Dec 8, 2025Rich StuartChief Medical Officer, DirectorBuy(P)3K$10.10$25K
Dec 4, 2025Rich StuartChief Medical Officer, DirectorBuy(P)3K$9.20$23K
Dec 3, 2025Rich StuartChief Medical Officer, DirectorBuy(P)2K$9.08$14K
Dec 2, 2025Rich StuartChief Medical Officer, DirectorBuy(P)1K$9.01$9K
Nov 20, 2025Giordano Christopher ThomasCEO, DirectorBuy(P)538$7.59$4K
Nov 19, 2025Giordano Christopher ThomasCEO, DirectorBuy(P)455$7.51$3K
Nov 18, 2025Almenoff June SherieDirectorBuy(P)2K$7.52$14K
Nov 18, 2025Giordano Christopher ThomasCEO, DirectorBuy(P)2K$7.75$12K
Nov 17, 2025Almenoff June SherieDirectorBuy(P)93$7.15$665
Nov 17, 2025McGauley ThomasInterim CFOBuy(P)5K$7.23$36K
Nov 17, 2025McGauley ThomasInterim CFOBuy(P)1K$7.35$7K
Nov 17, 2025McGauley ThomasInterim CFOBuy(P)2K$7.34$15K
Jul 1, 2025Hunter RobynDirectorGrant(A)80K—$0
Jul 1, 2025Proehl Gerald TDirectorGrant(A)80K—$0
Jul 1, 2025Doogan DeclanDirectorGrant(A)80K—$0
Jul 1, 2025Davidson Michael H.DirectorGrant(A)80K—$0
Jul 1, 2025Almenoff June SherieDirectorGrant(A)80K—$0
May 16, 2025Giordano Christopher ThomasCEO, DirectorGrant(A)1.4M—$0
May 16, 2025Rich StuartChief Medical Officer, DirectorGrant(A)625K—$0
Dec 10, 2024Almenoff June SherieDirectorGrant(A)100K—$0
Dec 10, 2024Davidson Michael H.DirectorGrant(A)100K—$0
Dec 10, 2024Doogan DeclanDirectorGrant(A)100K—$0
Dec 10, 2024Giordano Christopher ThomasCEO, DirectorGrant(A)1.3M—$0
Dec 10, 2024Hunter RobynDirectorGrant(A)100K—$0
Dec 10, 2024Proehl Gerald TDirectorGrant(A)100K—$0
Dec 10, 2024Rich StuartChief Medical Officer, DirectorGrant(A)500K—$0
Aug 8, 2024Davidson Michael H.DirectorBuy(P)3K——
Aug 8, 2024Davidson Michael H.DirectorBuy(P)48K——
Aug 8, 2024Davidson Michael H.DirectorBuy(P)25K——
Aug 8, 2024Proehl Gerald TDirectorBuy(P)2K——
Aug 8, 2024Proehl Gerald TDirectorBuy(P)32K——
Aug 8, 2024Proehl Gerald TDirectorBuy(P)17K——
May 17, 2024Giordano Christopher ThomasCEO, DirectorGrant(A)437—$0
May 17, 2024Rich StuartChief Medical Officer, DirectorGrant(A)119—$0
Sep 21, 2022Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Sep 21, 2022Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Aug 11, 2022Doogan DeclanDirector, 10% OwnerGift(G)568K—$0
Aug 11, 2022Doogan DeclanDirector, 10% OwnerGift(G)568K—$0
Jun 9, 2022Almenoff June SherieDirectorGrant(A)5K—$0
Jun 9, 2022Davidson Michael H.DirectorGrant(A)5K—$0
Jun 9, 2022Doogan DeclanDirector, 10% OwnerGrant(A)5K—$0
Jun 9, 2022Giordano Christopher ThomasCEO, DirectorGrant(A)200K—$0
Jun 9, 2022Hunter RobynDirectorGrant(A)6K—$0
Jun 9, 2022Proehl Gerald TDirectorGrant(A)5K—$0
Jun 9, 2022Rich StuartChief Medical Officer, Director, 10% OwnerGrant(A)100K—$0
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)2.1M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerDisposed to issuer(D)2.1M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)2.4M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)4.8M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)4.6M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)10.6M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerDisposed to issuer(D)4.6M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)3.2M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerDisposed to issuer(D)3.2M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerGrant(A)10.6M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerDisposed to issuer(D)4.8M——
May 18, 2022Armistice Capital Master Fund Ltd.Director, 10% OwnerDisposed to issuer(D)2.4M——
Nov 29, 2021Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Nov 29, 2021Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Oct 12, 2021Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Oct 12, 2021Rich StuartChief Medical Officer, Director, 10% OwnerGift(G)1.9M—$0
Jul 8, 2021Boyd StevenDirectorGrant(A)4.8M——
Jul 8, 2021Boyd StevenDirectorGrant(A)4.8M——
Jul 6, 2021DiTonno Anthony ACEO, DirectorGrant(A)50K—$0
Jun 30, 2021Doogan DeclanDirector, 10% OwnerGift(G)568K—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).